Project Number CIHR-QURESHI-2013 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2013 View Full Project Details for Establishing the relevance of eukaryotic elongation factor-2 kinase inhibition as a novel therapeutic strategy for the treatment of Alzheimer's disease and related dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Category F. Research Resources 3. Professional and Career Development b. Fellowships Researcher and Organization Principal Investigator QURESHI, Muhammad Asad J Principal Investigator First Name Muhammad Asad J Principal Investigator Last Name QURESHI Awardee Organization BC Cancer Agency (Vancouver, BC) Contact PI Country Canada Project Detail FY Overall Cost $45,000 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada
